Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy
1 clinical trials · Condition
◉ Watch Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy
| Record | Firm | Date |
|---|---|---|
| A Multicenter Phase III Clinical Study and Translational Research on Adaptive Neoadjuvant Therapy of De-escalation and Escalation for HER2-Positive Breast Cancer Based on Multi-Omics Response Evaluation Model (NCT07239271) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-11-16 |
Track Patients With HER2-positive Breast Cancer (BC) Suitable for Neoadjuvant Therapy automatically
Every clearance here is in the API, with alerts when new ones post.